PT1379273E - Adjuvantes à base de ácidos nucleicos - Google Patents

Info

Publication number

PT1379273E

PT1379273E PT01274277T PT01274277T PT1379273E PT 1379273 E PT1379273 E PT 1379273E PT 01274277 T PT01274277 T PT 01274277T PT 01274277 T PT01274277 T PT 01274277T PT 1379273 E PT1379273 E PT 1379273E

Authority

PT

Portugal

Prior art keywords

antigen

quot

dna

nucleic acid

subunit

Prior art date

2000-11-27

Links

• Espacenet
• Global Dossier
• Discuss

• 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 123
• 239000002671 adjuvant Substances 0.000 title claims description 156
• 102000039446 nucleic acids Human genes 0.000 title abstract description 60
• 108020004707 nucleic acids Proteins 0.000 title abstract description 60
• 239000000203 mixture Substances 0.000 claims abstract description 324
• 239000013598 vector Substances 0.000 claims abstract description 217
• 239000000427 antigen Substances 0.000 claims abstract description 207
• 108091007433 antigens Proteins 0.000 claims abstract description 207
• 102000036639 antigens Human genes 0.000 claims abstract description 207
• 108091026890 Coding region Proteins 0.000 claims abstract description 102
• 238000000034 method Methods 0.000 claims abstract description 100
• 230000028993 immune response Effects 0.000 claims abstract description 54
• 239000002095 exotoxin Substances 0.000 claims abstract description 53
• 231100000776 exotoxin Toxicity 0.000 claims abstract description 53
• OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 claims abstract description 51
• 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 45
• 230000001580 bacterial effect Effects 0.000 claims abstract description 41
• 230000002708 enhancing effect Effects 0.000 claims abstract description 4
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 138
• 239000002245 particle Substances 0.000 claims description 138
• 229910052737 gold Inorganic materials 0.000 claims description 137
• 239000010931 gold Substances 0.000 claims description 137
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 128
• 210000004027 cell Anatomy 0.000 claims description 71
• 230000005730 ADP ribosylation Effects 0.000 claims description 58
• 108090000623 proteins and genes Proteins 0.000 claims description 46
• 241000700605 Viruses Species 0.000 claims description 30
• 241000699670 Mus sp. Species 0.000 claims description 29
• 239000013566 allergen Substances 0.000 claims description 28
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 28
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 20
• 230000001404 mediated effect Effects 0.000 claims description 19
• 241000701074 Human alphaherpesvirus 2 Species 0.000 claims description 17
• 238000002360 preparation method Methods 0.000 claims description 16
• 210000004962 mammalian cell Anatomy 0.000 claims description 15
• 238000004519 manufacturing process Methods 0.000 claims description 15
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 13
• 230000028327 secretion Effects 0.000 claims description 13
• 241000588724 Escherichia coli Species 0.000 claims description 12
• 238000012217 deletion Methods 0.000 claims description 12
• 230000037430 deletion Effects 0.000 claims description 12
• 241000700584 Simplexvirus Species 0.000 claims description 11
• 244000052769 pathogen Species 0.000 claims description 11
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 11
• 239000003814 drug Substances 0.000 claims description 10
• 206010028980 Neoplasm Diseases 0.000 claims description 9
• 210000004899 c-terminal region Anatomy 0.000 claims description 9
• 239000000147 enterotoxin Substances 0.000 claims description 9
• 231100000655 enterotoxin Toxicity 0.000 claims description 9
• 101710146739 Enterotoxin Proteins 0.000 claims description 8
• 102000004190 Enzymes Human genes 0.000 claims description 8
• 108090000790 Enzymes Proteins 0.000 claims description 8
• 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 8
• 238000002835 absorbance Methods 0.000 claims description 7
• 230000001717 pathogenic effect Effects 0.000 claims description 7
• 239000003937 drug carrier Substances 0.000 claims description 6
• 229910052751 metal Inorganic materials 0.000 claims description 6
• 239000002184 metal Substances 0.000 claims description 6
• 230000003071 parasitic effect Effects 0.000 claims description 4
• 241000712461 unidentified influenza virus Species 0.000 claims description 4
• 241001631646 Papillomaviridae Species 0.000 claims description 3
• 208000006454 hepatitis Diseases 0.000 claims description 3
• 231100000283 hepatitis Toxicity 0.000 claims description 3
• 230000000638 stimulation Effects 0.000 claims description 3
• 244000052613 viral pathogen Species 0.000 claims description 3
• 108020004638 Circular DNA Proteins 0.000 claims 6
• 244000052616 bacterial pathogen Species 0.000 claims 2
• 101150084750 1 gene Proteins 0.000 claims 1
• 102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 claims 1
• 101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 claims 1
• 101000856513 Homo sapiens Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Proteins 0.000 claims 1
• 102100025509 Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Human genes 0.000 claims 1
• 241000124008 Mammalia Species 0.000 claims 1
• 101100293593 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nar-1 gene Proteins 0.000 claims 1
• 201000008754 Tenosynovial giant cell tumor Diseases 0.000 claims 1
• PWOSZCQLSAMRQW-UHFFFAOYSA-N beryllium(2+) Chemical compound [Be+2] PWOSZCQLSAMRQW-UHFFFAOYSA-N 0.000 claims 1
• 208000035647 diffuse type tenosynovial giant cell tumor Diseases 0.000 claims 1
• 208000002918 testicular germ cell tumor Diseases 0.000 claims 1
• 108020004414 DNA Proteins 0.000 description 197
• 238000009472 formulation Methods 0.000 description 160
• 239000013612 plasmid Substances 0.000 description 106
• 239000012634 fragment Substances 0.000 description 57
• 241001465754 Metazoa Species 0.000 description 56
• 102000040430 polynucleotide Human genes 0.000 description 55
• 108091033319 polynucleotide Proteins 0.000 description 55
• 239000002157 polynucleotide Substances 0.000 description 55
• 108010049048 Cholera Toxin Proteins 0.000 description 51
• 102000009016 Cholera Toxin Human genes 0.000 description 51
• 230000003053 immunization Effects 0.000 description 50
• 238000002649 immunization Methods 0.000 description 50
• 229960005486 vaccine Drugs 0.000 description 48
• 238000003752 polymerase chain reaction Methods 0.000 description 47
• 239000013600 plasmid vector Substances 0.000 description 45
• 239000003053 toxin Substances 0.000 description 42
• 231100000765 toxin Toxicity 0.000 description 42
• 108700012359 toxins Proteins 0.000 description 42
• 239000013615 primer Substances 0.000 description 41
• 108010074328 Interferon-gamma Proteins 0.000 description 34
• 102100037850 Interferon gamma Human genes 0.000 description 33
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 33
• 239000002953 phosphate buffered saline Substances 0.000 description 33
• 229940021995 DNA vaccine Drugs 0.000 description 29
• 108010041986 DNA Vaccines Proteins 0.000 description 28
• 238000006243 chemical reaction Methods 0.000 description 28
• 101710132601 Capsid protein Proteins 0.000 description 27
• 102100026238 Lymphotoxin-alpha Human genes 0.000 description 27
• 239000002773 nucleotide Substances 0.000 description 24
• 125000003729 nucleotide group Chemical group 0.000 description 23
• 238000002965 ELISA Methods 0.000 description 19
• 230000000240 adjuvant effect Effects 0.000 description 19
• 239000000047 product Substances 0.000 description 19
• 101710130522 mRNA export factor Proteins 0.000 description 18
• 102000004169 proteins and genes Human genes 0.000 description 18
• 235000018102 proteins Nutrition 0.000 description 17
• 210000002966 serum Anatomy 0.000 description 17
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 16
• 230000000694 effects Effects 0.000 description 15
• 238000002347 injection Methods 0.000 description 15
• 239000007924 injection Substances 0.000 description 15
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
• 241000725303 Human immunodeficiency virus Species 0.000 description 14
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 14
• 230000004044 response Effects 0.000 description 14
• 230000003612 virological effect Effects 0.000 description 14
• 208000002672 hepatitis B Diseases 0.000 description 13
• 239000000243 solution Substances 0.000 description 13
• 241000701022 Cytomegalovirus Species 0.000 description 12
• 239000013604 expression vector Substances 0.000 description 12
• 238000003780 insertion Methods 0.000 description 12
• 230000037431 insertion Effects 0.000 description 12
• 238000001556 precipitation Methods 0.000 description 12
• 230000010076 replication Effects 0.000 description 12
• ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 12
• 239000000126 substance Substances 0.000 description 12
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
• 238000011510 Elispot assay Methods 0.000 description 11
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
• 238000007792 addition Methods 0.000 description 11
• 150000001413 amino acids Chemical class 0.000 description 11
• 238000003556 assay Methods 0.000 description 11
• 239000000969 carrier Substances 0.000 description 11
• 238000010367 cloning Methods 0.000 description 11
• 238000011161 development Methods 0.000 description 11
• 229940065638 intron a Drugs 0.000 description 11
• 239000007788 liquid Substances 0.000 description 11
• 210000004988 splenocyte Anatomy 0.000 description 11
• 210000001519 tissue Anatomy 0.000 description 11
• 239000013603 viral vector Substances 0.000 description 11
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 10
• 238000010790 dilution Methods 0.000 description 10
• 239000012895 dilution Substances 0.000 description 10
• 238000001415 gene therapy Methods 0.000 description 10
• 230000001976 improved effect Effects 0.000 description 10
• 230000008488 polyadenylation Effects 0.000 description 10
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 9
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 9
• 229920001213 Polysorbate 20 Polymers 0.000 description 9
• 230000024932 T cell mediated immunity Effects 0.000 description 9
• 238000000576 coating method Methods 0.000 description 9
• 238000002474 experimental method Methods 0.000 description 9
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 9
• 238000013518 transcription Methods 0.000 description 9
• 230000035897 transcription Effects 0.000 description 9
• 238000001890 transfection Methods 0.000 description 9
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 8
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 8
• 108090000978 Interleukin-4 Proteins 0.000 description 8
• 241000699666 Mus <mouse, genus> Species 0.000 description 8
• 125000003275 alpha amino acid group Chemical group 0.000 description 8
• 239000011248 coating agent Substances 0.000 description 8
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 8
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
• 239000003623 enhancer Substances 0.000 description 8
• 210000002615 epidermis Anatomy 0.000 description 8
• 230000006870 function Effects 0.000 description 8
• 238000001727 in vivo Methods 0.000 description 8
• 238000011081 inoculation Methods 0.000 description 8
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 8
• 238000011160 research Methods 0.000 description 8
• 238000012360 testing method Methods 0.000 description 8
• 241000701161 unidentified adenovirus Species 0.000 description 8
• 238000012286 ELISA Assay Methods 0.000 description 7
• 239000002253 acid Substances 0.000 description 7
• 150000007513 acids Chemical class 0.000 description 7
• 230000015572 biosynthetic process Effects 0.000 description 7
• 201000010099 disease Diseases 0.000 description 7
• 230000006872 improvement Effects 0.000 description 7
• 239000000463 material Substances 0.000 description 7
• 239000002609 medium Substances 0.000 description 7
• 108020004999 messenger RNA Proteins 0.000 description 7
• 239000000843 powder Substances 0.000 description 7
• 230000009467 reduction Effects 0.000 description 7
• 210000003491 skin Anatomy 0.000 description 7
• 210000000952 spleen Anatomy 0.000 description 7
• WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 7
• 229910052721 tungsten Inorganic materials 0.000 description 7
• 239000010937 tungsten Substances 0.000 description 7
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
• 108700002232 Immediate-Early Genes Proteins 0.000 description 6
• 102100034349 Integrase Human genes 0.000 description 6
• 102000000440 Melanoma-associated antigen Human genes 0.000 description 6
• 108050008953 Melanoma-associated antigen Proteins 0.000 description 6
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 6
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 6
• 230000005875 antibody response Effects 0.000 description 6
• 239000000872 buffer Substances 0.000 description 6
• 239000003795 chemical substances by application Substances 0.000 description 6
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
• 238000010276 construction Methods 0.000 description 6
• 238000011534 incubation Methods 0.000 description 6
• 238000007918 intramuscular administration Methods 0.000 description 6
• 238000010369 molecular cloning Methods 0.000 description 6
• 238000004806 packaging method and process Methods 0.000 description 6
• 238000010647 peptide synthesis reaction Methods 0.000 description 6
• 229920001223 polyethylene glycol Polymers 0.000 description 6
• 229920001184 polypeptide Polymers 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• 229940063673 spermidine Drugs 0.000 description 6
• 238000003786 synthesis reaction Methods 0.000 description 6
• 229960000187 tissue plasminogen activator Drugs 0.000 description 6
• 231100000419 toxicity Toxicity 0.000 description 6
• 230000001988 toxicity Effects 0.000 description 6
• 238000013519 translation Methods 0.000 description 6
• 230000014616 translation Effects 0.000 description 6
• UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 5
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
• 102000003992 Peroxidases Human genes 0.000 description 5
• 241000282887 Suidae Species 0.000 description 5
• 210000001744 T-lymphocyte Anatomy 0.000 description 5
• 230000003321 amplification Effects 0.000 description 5
• 108010006025 bovine growth hormone Proteins 0.000 description 5
• 239000002299 complementary DNA Substances 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 239000012091 fetal bovine serum Substances 0.000 description 5
• 239000007789 gas Substances 0.000 description 5
• 210000004379 membrane Anatomy 0.000 description 5
• 239000012528 membrane Substances 0.000 description 5
• 238000003199 nucleic acid amplification method Methods 0.000 description 5
• 108040007629 peroxidase activity proteins Proteins 0.000 description 5
• 239000002987 primer (paints) Substances 0.000 description 5
• 238000011282 treatment Methods 0.000 description 5
• 239000012646 vaccine adjuvant Substances 0.000 description 5
• 239000011534 wash buffer Substances 0.000 description 5
• 238000005406 washing Methods 0.000 description 5
• 241000588832 Bordetella pertussis Species 0.000 description 4
• 241000283707 Capra Species 0.000 description 4
• 108020004705 Codon Proteins 0.000 description 4
• 239000003155 DNA primer Substances 0.000 description 4
• 238000011238 DNA vaccination Methods 0.000 description 4
• 241000196324 Embryophyta Species 0.000 description 4
• 241000282326 Felis catus Species 0.000 description 4
• 108700026244 Open Reading Frames Proteins 0.000 description 4
• 241000607626 Vibrio cholerae Species 0.000 description 4
• 238000004458 analytical method Methods 0.000 description 4
• 238000013459 approach Methods 0.000 description 4
• 244000309466 calf Species 0.000 description 4
• 230000007969 cellular immunity Effects 0.000 description 4
• 230000036755 cellular response Effects 0.000 description 4
• 238000005516 engineering process Methods 0.000 description 4
• 230000028996 humoral immune response Effects 0.000 description 4
• 238000011065 in-situ storage Methods 0.000 description 4
• 208000015181 infectious disease Diseases 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 239000002502 liposome Substances 0.000 description 4
• 229920002521 macromolecule Polymers 0.000 description 4
• 238000012737 microarray-based gene expression Methods 0.000 description 4
• 210000004400 mucous membrane Anatomy 0.000 description 4
• 238000012243 multiplex automated genomic engineering Methods 0.000 description 4
• 230000035772 mutation Effects 0.000 description 4
• 230000003287 optical effect Effects 0.000 description 4
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
• 239000007790 solid phase Substances 0.000 description 4
• 238000010561 standard procedure Methods 0.000 description 4
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
• 239000003104 tissue culture media Substances 0.000 description 4
• 230000037317 transdermal delivery Effects 0.000 description 4
• 241001430294 unidentified retrovirus Species 0.000 description 4
• 239000013607 AAV vector Substances 0.000 description 3
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• 231100000699 Bacterial toxin Toxicity 0.000 description 3
• -1 Cationic lipid Chemical class 0.000 description 3
• 206010009944 Colon cancer Diseases 0.000 description 3
• 102000053602 DNA Human genes 0.000 description 3
• 229920002307 Dextran Polymers 0.000 description 3
• 108010053187 Diphtheria Toxin Proteins 0.000 description 3
• 102000016607 Diphtheria Toxin Human genes 0.000 description 3
• 241000991587 Enterovirus C Species 0.000 description 3
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
• 241000233866 Fungi Species 0.000 description 3
• 241000287828 Gallus gallus Species 0.000 description 3
• 239000004471 Glycine Substances 0.000 description 3
• 241000700721 Hepatitis B virus Species 0.000 description 3
• 241000238631 Hexapoda Species 0.000 description 3
• 206010020751 Hypersensitivity Diseases 0.000 description 3
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 3
• 108091034117 Oligonucleotide Proteins 0.000 description 3
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 229920006355 Tefzel Polymers 0.000 description 3
• 102100023038 WD and tetratricopeptide repeats protein 1 Human genes 0.000 description 3
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
• 230000003187 abdominal effect Effects 0.000 description 3
• 208000026935 allergic disease Diseases 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 230000000890 antigenic effect Effects 0.000 description 3
• 239000000688 bacterial toxin Substances 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000027455 binding Effects 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 239000001506 calcium phosphate Substances 0.000 description 3
• 235000011010 calcium phosphates Nutrition 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 235000013330 chicken meat Nutrition 0.000 description 3
• 239000013599 cloning vector Substances 0.000 description 3
• 231100000676 disease causative agent Toxicity 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• QHSJIZLJUFMIFP-UHFFFAOYSA-N ethene;1,1,2,2-tetrafluoroethene Chemical compound C=C.FC(F)=C(F)F QHSJIZLJUFMIFP-UHFFFAOYSA-N 0.000 description 3
• 238000004108 freeze drying Methods 0.000 description 3
• 238000001476 gene delivery Methods 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 239000001307 helium Substances 0.000 description 3
• 229910052734 helium Inorganic materials 0.000 description 3
• SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 3
• 210000002443 helper t lymphocyte Anatomy 0.000 description 3
• 230000008348 humoral response Effects 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• 230000005847 immunogenicity Effects 0.000 description 3
• 238000000338 in vitro Methods 0.000 description 3
• 201000001441 melanoma Diseases 0.000 description 3
• 235000013336 milk Nutrition 0.000 description 3
• 239000008267 milk Substances 0.000 description 3
• 210000004080 milk Anatomy 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 238000001823 molecular biology technique Methods 0.000 description 3
• 239000013642 negative control Substances 0.000 description 3
• 239000008194 pharmaceutical composition Substances 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• 230000003389 potentiating effect Effects 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 230000002685 pulmonary effect Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 230000000241 respiratory effect Effects 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 230000001177 retroviral effect Effects 0.000 description 3
• 235000020183 skimmed milk Nutrition 0.000 description 3
• 241000894007 species Species 0.000 description 3
• PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical class NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 3
• 210000004989 spleen cell Anatomy 0.000 description 3
• 239000003381 stabilizer Substances 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
• 239000003656 tris buffered saline Substances 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• 229940118696 vibrio cholerae Drugs 0.000 description 3
• HDTRYLNUVZCQOY-UHFFFAOYSA-N &alpha;-D-glucopyranosyl-&alpha;-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
• IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 2
• 102000009062 ADP Ribose Transferases Human genes 0.000 description 2
• 108010049290 ADP Ribose Transferases Proteins 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 208000004881 Amebiasis Diseases 0.000 description 2
• 206010001980 Amoebiasis Diseases 0.000 description 2
• 241001465677 Ancylostomatoidea Species 0.000 description 2
• 241000272517 Anseriformes Species 0.000 description 2
• 101100098918 Arabidopsis thaliana TFCA gene Proteins 0.000 description 2
• ZATRYQNPUHGXCU-DTWKUNHWSA-N Arg-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ZATRYQNPUHGXCU-DTWKUNHWSA-N 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 235000018185 Betula X alpestris Nutrition 0.000 description 2
• 235000018212 Betula X uliginosa Nutrition 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• 244000025254 Cannabis sativa Species 0.000 description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
• 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 2
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
• 108020004635 Complementary DNA Proteins 0.000 description 2
• 241000711573 Coronaviridae Species 0.000 description 2
• 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 2
• 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 2
• 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 2
• 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 2
• 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
• 241000709661 Enterovirus Species 0.000 description 2
• 101710121417 Envelope glycoprotein Proteins 0.000 description 2
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
• 108091006027 G proteins Proteins 0.000 description 2
• 241000531123 GB virus C Species 0.000 description 2
• 102000030782 GTP binding Human genes 0.000 description 2
• 108091000058 GTP-Binding Proteins 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• JXYMPBCYRKWJEE-BQBZGAKWSA-N Gly-Arg-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JXYMPBCYRKWJEE-BQBZGAKWSA-N 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 229910003556 H2 SO4 Inorganic materials 0.000 description 2
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 2
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 2
• 241000724675 Hepatitis E virus Species 0.000 description 2
• 241000724709 Hepatitis delta virus Species 0.000 description 2
• 241000709721 Hepatovirus A Species 0.000 description 2
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
• 239000004705 High-molecular-weight polyethylene Substances 0.000 description 2
• 108010000521 Human Growth Hormone Proteins 0.000 description 2
• 102000002265 Human Growth Hormone Human genes 0.000 description 2
• 239000000854 Human Growth Hormone Substances 0.000 description 2
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 2
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 101900330356 Influenza A virus Matrix protein 2 Proteins 0.000 description 2
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 102100037611 Lysophospholipase Human genes 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 241000712079 Measles morbillivirus Species 0.000 description 2
• 208000005647 Mumps Diseases 0.000 description 2
• 241000711386 Mumps virus Species 0.000 description 2
• 108010086093 Mung Bean Nuclease Proteins 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
• 229930182555 Penicillin Natural products 0.000 description 2
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
• 108010081690 Pertussis Toxin Proteins 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 108010058864 Phospholipases A2 Proteins 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 241000219000 Populus Species 0.000 description 2
• 206010057190 Respiratory tract infections Diseases 0.000 description 2
• 241000702670 Rotavirus Species 0.000 description 2
• 241000710799 Rubella virus Species 0.000 description 2
• 101150038853 Segment-7 gene Proteins 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 108010006785 Taq Polymerase Proteins 0.000 description 2
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
• 108020005038 Terminator Codon Proteins 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 101800001690 Transmembrane protein gp41 Proteins 0.000 description 2
• HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
• 206010044608 Trichiniasis Diseases 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 108010067390 Viral Proteins Proteins 0.000 description 2
• 108020000999 Viral RNA Proteins 0.000 description 2
• 241000607479 Yersinia pestis Species 0.000 description 2
• 239000012190 activator Substances 0.000 description 2
• 108010011559 alanylphenylalanine Proteins 0.000 description 2
• 230000007815 allergy Effects 0.000 description 2
• HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
• 125000000539 amino acid group Chemical group 0.000 description 2
• 239000012491 analyte Substances 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 230000008350 antigen-specific antibody response Effects 0.000 description 2
• 108010091092 arginyl-glycyl-proline Proteins 0.000 description 2
• 239000003659 bee venom Substances 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 210000000481 breast Anatomy 0.000 description 2
• 239000007853 buffer solution Substances 0.000 description 2
• 239000001110 calcium chloride Substances 0.000 description 2
• 235000011148 calcium chloride Nutrition 0.000 description 2
• 229910001628 calcium chloride Inorganic materials 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 125000002091 cationic group Chemical group 0.000 description 2
• 239000006285 cell suspension Substances 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 235000015165 citric acid Nutrition 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 238000012411 cloning technique Methods 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 239000000599 controlled substance Substances 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 238000002716 delivery method Methods 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 239000003599 detergent Substances 0.000 description 2
• 239000008121 dextrose Substances 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 229940079920 digestives acid preparations Drugs 0.000 description 2
• 239000013024 dilution buffer Substances 0.000 description 2
• 239000012153 distilled water Substances 0.000 description 2
• 238000012377 drug delivery Methods 0.000 description 2
• 230000009977 dual effect Effects 0.000 description 2
• 235000013601 eggs Nutrition 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• 231100000249 enterotoxic Toxicity 0.000 description 2
• 230000002242 enterotoxic effect Effects 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 101150077745 ex gene Proteins 0.000 description 2
• 239000002360 explosive Substances 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 102000034356 gene-regulatory proteins Human genes 0.000 description 2
• 108091006104 gene-regulatory proteins Proteins 0.000 description 2
• 201000006592 giardiasis Diseases 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 229920002674 hyaluronan Polymers 0.000 description 2
• 229960003160 hyaluronic acid Drugs 0.000 description 2
• 150000003840 hydrochlorides Chemical class 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 206010022000 influenza Diseases 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 229910052500 inorganic mineral Inorganic materials 0.000 description 2
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
• 229960000367 inositol Drugs 0.000 description 2
• 230000000968 intestinal effect Effects 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000010253 intravenous injection Methods 0.000 description 2
• FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 239000004816 latex Substances 0.000 description 2
• 229920000126 latex Polymers 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 238000011068 loading method Methods 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 238000005374 membrane filtration Methods 0.000 description 2
• 150000002739 metals Chemical class 0.000 description 2
• 239000011707 mineral Substances 0.000 description 2
• 235000010755 mineral Nutrition 0.000 description 2
• 239000002480 mineral oil Substances 0.000 description 2
• 235000010446 mineral oil Nutrition 0.000 description 2
• 208000010805 mumps infectious disease Diseases 0.000 description 2
• 230000007935 neutral effect Effects 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 229940023146 nucleic acid vaccine Drugs 0.000 description 2
• 238000002515 oligonucleotide synthesis Methods 0.000 description 2
• 150000007524 organic acids Chemical class 0.000 description 2
• 235000005985 organic acids Nutrition 0.000 description 2
• 239000006179 pH buffering agent Substances 0.000 description 2
• 229940049954 penicillin Drugs 0.000 description 2
• 239000000816 peptidomimetic Substances 0.000 description 2
• 239000008177 pharmaceutical agent Substances 0.000 description 2
• 239000000825 pharmaceutical preparation Substances 0.000 description 2
• 235000021317 phosphate Nutrition 0.000 description 2
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
• 229910052697 platinum Inorganic materials 0.000 description 2
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
• 244000144977 poultry Species 0.000 description 2
• 235000013594 poultry meat Nutrition 0.000 description 2
• 230000001376 precipitating effect Effects 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 239000011535 reaction buffer Substances 0.000 description 2
• 239000011541 reaction mixture Substances 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 238000010188 recombinant method Methods 0.000 description 2
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 108700004030 rev Genes Proteins 0.000 description 2
• 101150098213 rev gene Proteins 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 239000000523 sample Substances 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000001488 sodium phosphate Substances 0.000 description 2
• 235000011008 sodium phosphates Nutrition 0.000 description 2
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 239000007921 spray Substances 0.000 description 2
• 238000001694 spray drying Methods 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 229940031626 subunit vaccine Drugs 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 239000011975 tartaric acid Substances 0.000 description 2
• 235000002906 tartaric acid Nutrition 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 229940113082 thymine Drugs 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 230000005030 transcription termination Effects 0.000 description 2
• 238000013271 transdermal drug delivery Methods 0.000 description 2
• 238000012281 transfemoral cerebral angiography Methods 0.000 description 2
• 208000003982 trichinellosis Diseases 0.000 description 2
• 201000007588 trichinosis Diseases 0.000 description 2
• 201000008827 tuberculosis Diseases 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 230000003827 upregulation Effects 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 238000009736 wetting Methods 0.000 description 2
• 239000000080 wetting agent Substances 0.000 description 2
• PAYBYKKERMGTSS-MNCSTQPFSA-N (2r,3r,3as,9ar)-7-fluoro-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydrofuro[1,2][1,3]oxazolo[3,4-a]pyrimidin-3-ol Chemical compound N=C1C(F)=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3OC2=N1 PAYBYKKERMGTSS-MNCSTQPFSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
• LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 1
• RSMRWWHFJMENJH-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC RSMRWWHFJMENJH-LQDDAWAPSA-M 0.000 description 1
• KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• XZKIHKMTEMTJQX-UHFFFAOYSA-L 4-nitrophenyl phosphate(2-) Chemical compound [O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-L 0.000 description 1
• UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
• 241000238876 Acari Species 0.000 description 1
• 102100039819 Actin, alpha cardiac muscle 1 Human genes 0.000 description 1
• 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 1
• 241000186361 Actinobacteria <class> Species 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 241000580270 Adeno-associated virus - 4 Species 0.000 description 1
• 241000844498 Agatea Species 0.000 description 1
• 241000223600 Alternaria Species 0.000 description 1
• 240000001592 Amaranthus caudatus Species 0.000 description 1
• 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
• 244000036975 Ambrosia artemisiifolia Species 0.000 description 1
• 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 1
• 244000105624 Arachis hypogaea Species 0.000 description 1
• 241000712892 Arenaviridae Species 0.000 description 1
• QYLJIYOGHRGUIH-CIUDSAMLSA-N Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N QYLJIYOGHRGUIH-CIUDSAMLSA-N 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 201000002909 Aspergillosis Diseases 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 208000036641 Aspergillus infections Diseases 0.000 description 1
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
• 241000726103 Atta Species 0.000 description 1
• 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 208000004429 Bacillary Dysentery Diseases 0.000 description 1
• 108020000946 Bacterial DNA Proteins 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 241000702628 Birnaviridae Species 0.000 description 1
• 241000588780 Bordetella parapertussis Species 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 101800001415 Bri23 peptide Proteins 0.000 description 1
• 241000589562 Brucella Species 0.000 description 1
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
• 101800000655 C-terminal peptide Proteins 0.000 description 1
• 102400000107 C-terminal peptide Human genes 0.000 description 1
• 102100031168 CCN family member 2 Human genes 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 description 1
• 101000946068 Caenorhabditis elegans Ceramide glucosyltransferase 3 Proteins 0.000 description 1
• 101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 1
• 241000714198 Caliciviridae Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 206010007134 Candida infections Diseases 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
• 241001137903 Centropomus pectinatus Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 240000001817 Cereus hexagonus Species 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241000242722 Cestoda Species 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 108010062745 Chloride Channels Proteins 0.000 description 1
• 102000011045 Chloride Channels Human genes 0.000 description 1
• 206010008631 Cholera Diseases 0.000 description 1
• 102100029173 Choline-phosphate cytidylyltransferase B Human genes 0.000 description 1
• 101710100756 Choline-phosphate cytidylyltransferase B Proteins 0.000 description 1
• 241000251556 Chordata Species 0.000 description 1
• 241000193163 Clostridioides difficile Species 0.000 description 1
• 241000193155 Clostridium botulinum Species 0.000 description 1
• 241000193468 Clostridium perfringens Species 0.000 description 1
• 241000254173 Coleoptera Species 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 229920000742 Cotton Polymers 0.000 description 1
• 241000238424 Crustacea Species 0.000 description 1
• 241000223935 Cryptosporidium Species 0.000 description 1
• 201000003883 Cystic fibrosis Diseases 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 241000450599 DNA viruses Species 0.000 description 1
• 241000725619 Dengue virus Species 0.000 description 1
• 241000238710 Dermatophagoides Species 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 101710091045 Envelope protein Proteins 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 108700024394 Exon Proteins 0.000 description 1
• 241000234642 Festuca Species 0.000 description 1
• 201000006353 Filariasis Diseases 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 241000710781 Flaviviridae Species 0.000 description 1
• 241000223218 Fusarium Species 0.000 description 1
• 101710177291 Gag polyprotein Proteins 0.000 description 1
• 241001123946 Gaga Species 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
• 206010048461 Genital infection Diseases 0.000 description 1
• UMZHHILWZBFPGL-LOKLDPHHSA-N Glu-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O UMZHHILWZBFPGL-LOKLDPHHSA-N 0.000 description 1
• BPCLDCNZBUYGOD-BPUTZDHNSA-N Glu-Trp-Glu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 BPCLDCNZBUYGOD-BPUTZDHNSA-N 0.000 description 1
• 108010068370 Glutens Proteins 0.000 description 1
• JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
• 206010018612 Gonorrhoea Diseases 0.000 description 1
• 206010018693 Granuloma inguinale Diseases 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 102000025850 HLA-A2 Antigen Human genes 0.000 description 1
• 108010074032 HLA-A2 Antigen Proteins 0.000 description 1
• 241000606768 Haemophilus influenzae Species 0.000 description 1
• 241000186568 Hathewaya limosa Species 0.000 description 1
• 241000589989 Helicobacter Species 0.000 description 1
• 241000590002 Helicobacter pylori Species 0.000 description 1
• 241000711549 Hepacivirus C Species 0.000 description 1
• 208000037262 Hepatitis delta Diseases 0.000 description 1
• 208000004898 Herpes Labialis Diseases 0.000 description 1
• 241001272567 Hominoidea Species 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000959247 Homo sapiens Actin, alpha cardiac muscle 1 Proteins 0.000 description 1
• 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
• 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 1
• 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
• 101000829958 Homo sapiens N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Proteins 0.000 description 1
• 101001128634 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial Proteins 0.000 description 1
• 101000617808 Homo sapiens Synphilin-1 Proteins 0.000 description 1
• 241000441510 Hormodendrum Species 0.000 description 1
• 108700020121 Human Immunodeficiency Virus-1 rev Proteins 0.000 description 1
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
• 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
• 241000598171 Human adenovirus sp. Species 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• BOTVMTSMOUSDRW-GMOBBJLQSA-N Ile-Arg-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(O)=O BOTVMTSMOUSDRW-GMOBBJLQSA-N 0.000 description 1
• BBIXOODYWPFNDT-CIUDSAMLSA-N Ile-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O BBIXOODYWPFNDT-CIUDSAMLSA-N 0.000 description 1
• 229940124873 Influenza virus vaccine Drugs 0.000 description 1
• 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 244000184861 Juglans nigra Species 0.000 description 1
• 241000588747 Klebsiella pneumoniae Species 0.000 description 1
• 241000589242 Legionella pneumophila Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 208000004554 Leishmaniasis Diseases 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• 208000016604 Lyme disease Diseases 0.000 description 1
• 102100035304 Lymphotactin Human genes 0.000 description 1
• 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 201000009906 Meningitis Diseases 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 241000588655 Moraxella catarrhalis Species 0.000 description 1
• 241000235395 Mucor Species 0.000 description 1
• 101100005318 Mus musculus Ctsr gene Proteins 0.000 description 1
• 101100135666 Mus musculus Paxbp1 gene Proteins 0.000 description 1
• 102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 description 1
• 102100032194 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial Human genes 0.000 description 1
• 101000783356 Naja sputatrix Cytotoxin Proteins 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 241000187654 Nocardia Species 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
• 102000011931 Nucleoproteins Human genes 0.000 description 1
• 108010061100 Nucleoproteins Proteins 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 241000243985 Onchocerca volvulus Species 0.000 description 1
• 206010067152 Oral herpes Diseases 0.000 description 1
• 241000712464 Orthomyxoviridae Species 0.000 description 1
• 206010033078 Otitis media Diseases 0.000 description 1
• 108010036616 P18-I10 peptide Proteins 0.000 description 1
• 208000002193 Pain Diseases 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241000711504 Paramyxoviridae Species 0.000 description 1
• 241000606856 Pasteurella multocida Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
• 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
• 241000150350 Peribunyaviridae Species 0.000 description 1
• 201000005702 Pertussis Diseases 0.000 description 1
• 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
• 244000046052 Phaseolus vulgaris Species 0.000 description 1
• 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• GXDPQJUBLBZKDY-IAVJCBSLSA-N Phe-Ile-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GXDPQJUBLBZKDY-IAVJCBSLSA-N 0.000 description 1
• 240000004713 Pisum sativum Species 0.000 description 1
• 235000010582 Pisum sativum Nutrition 0.000 description 1
• 206010035148 Plague Diseases 0.000 description 1
• 102000013566 Plasminogen Human genes 0.000 description 1
• 102100038124 Plasminogen Human genes 0.000 description 1
• 108010051456 Plasminogen Proteins 0.000 description 1
• 102000001938 Plasminogen Activators Human genes 0.000 description 1
• 108010001014 Plasminogen Activators Proteins 0.000 description 1
• 241000242594 Platyhelminthes Species 0.000 description 1
• 241000233872 Pneumocystis carinii Species 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 102000029797 Prion Human genes 0.000 description 1
• 108091000054 Prion Proteins 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 101710188315 Protein X Proteins 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 101000762949 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) Exotoxin A Proteins 0.000 description 1
• 102100033192 Puromycin-sensitive aminopeptidase Human genes 0.000 description 1
• 244000076686 Queensland pidgeon grass Species 0.000 description 1
• 235000016976 Quercus macrolepis Nutrition 0.000 description 1
• 241000711798 Rabies lyssavirus Species 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 208000035415 Reinfection Diseases 0.000 description 1
• 241000702247 Reoviridae Species 0.000 description 1
• 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
• 241000725643 Respiratory syncytial virus Species 0.000 description 1
• 241000712907 Retroviridae Species 0.000 description 1
• 241000711931 Rhabdoviridae Species 0.000 description 1
• 240000003152 Rhus chinensis Species 0.000 description 1
• 235000014220 Rhus chinensis Nutrition 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 101150071661 SLC25A20 gene Proteins 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 206010039438 Salmonella Infections Diseases 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 1
• VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
• TYIHBQYLIPJSIV-NYVOZVTQSA-N Ser-Trp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)O)NC(=O)[C@H](CO)N TYIHBQYLIPJSIV-NYVOZVTQSA-N 0.000 description 1
• 235000003232 Setaria pumila ssp. pallide fusca Nutrition 0.000 description 1
• 101150084276 Sgta gene Proteins 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 206010040550 Shigella infections Diseases 0.000 description 1
• 241000713311 Simian immunodeficiency virus Species 0.000 description 1
• 102100035254 Sodium- and chloride-dependent GABA transporter 3 Human genes 0.000 description 1
• 101710104417 Sodium- and chloride-dependent GABA transporter 3 Proteins 0.000 description 1
• 244000202761 Sorghum bicolor subsp verticilliflorum Species 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 108010088897 Staphylococcus aureus epidermal cell differentiation inhibitor Proteins 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 1
• 241000122938 Strongylus vulgaris Species 0.000 description 1
• 101100328105 Sus scrofa CLCA1 gene Proteins 0.000 description 1
• 241000779819 Syncarpia glomulifera Species 0.000 description 1
• 102100021997 Synphilin-1 Human genes 0.000 description 1
• SAQSTQBVENFSKT-UHFFFAOYSA-M TCA-sodium Chemical compound [Na+].[O-]C(=O)C(Cl)(Cl)Cl SAQSTQBVENFSKT-UHFFFAOYSA-M 0.000 description 1
• 240000002033 Tacca leontopetaloides Species 0.000 description 1
• 206010043376 Tetanus Diseases 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• LUMXICQAOKVQOB-YWIQKCBGSA-N Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O LUMXICQAOKVQOB-YWIQKCBGSA-N 0.000 description 1
• AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
• 241000710771 Tick-borne encephalitis virus Species 0.000 description 1
• 241000710924 Togaviridae Species 0.000 description 1
• 241000159243 Toxicodendron radicans Species 0.000 description 1
• 241000223996 Toxoplasma Species 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 102000004357 Transferases Human genes 0.000 description 1
• 108090000992 Transferases Proteins 0.000 description 1
• 208000005448 Trichomonas Infections Diseases 0.000 description 1
• 206010044620 Trichomoniasis Diseases 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 244000098338 Triticum aestivum Species 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 206010045240 Type I hypersensitivity Diseases 0.000 description 1
• 208000037386 Typhoid Diseases 0.000 description 1
• 108060008724 Tyrosinase Proteins 0.000 description 1
• 102000003425 Tyrosinase Human genes 0.000 description 1
• 235000009108 Urtica dioica Nutrition 0.000 description 1
• 241000218215 Urticaceae Species 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
• 210000001015 abdomen Anatomy 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• 239000000370 acceptor Substances 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• 201000007691 actinomycosis Diseases 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 108060000200 adenylate cyclase Proteins 0.000 description 1
• 102000030621 adenylate cyclase Human genes 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 238000007605 air drying Methods 0.000 description 1
• 230000002009 allergenic effect Effects 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 235000012735 amaranth Nutrition 0.000 description 1
• 239000004178 amaranth Substances 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 244000037640 animal pathogen Species 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 235000003484 annual ragweed Nutrition 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
• 238000003149 assay kit Methods 0.000 description 1
• 101150036080 at gene Proteins 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 239000003833 bile salt Substances 0.000 description 1
• 229940093761 bile salts Drugs 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 239000013575 birch pollen allergen Substances 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 229960003150 bupivacaine Drugs 0.000 description 1
• 235000006263 bur ragweed Nutrition 0.000 description 1
• 101150102633 cact gene Proteins 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 201000003984 candidiasis Diseases 0.000 description 1
• SEEZIOZEUUMJME-FOWTUZBSSA-N cannabigerolic acid Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-FOWTUZBSSA-N 0.000 description 1
• SEEZIOZEUUMJME-UHFFFAOYSA-N cannabinerolic acid Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-UHFFFAOYSA-N 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 239000002340 cardiotoxin Substances 0.000 description 1
• 231100000677 cardiotoxin Toxicity 0.000 description 1
• 210000000845 cartilage Anatomy 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 235000013351 cheese Nutrition 0.000 description 1
• 238000012412 chemical coupling Methods 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 238000011260 co-administration Methods 0.000 description 1
• 239000011247 coating layer Substances 0.000 description 1
• 235000003488 common ragweed Nutrition 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 239000013068 control sample Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 229940028617 conventional vaccine Drugs 0.000 description 1
• 239000002537 cosmetic Substances 0.000 description 1
• 239000008406 cosmetic ingredient Substances 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 239000008367 deionised water Substances 0.000 description 1
• 229910021641 deionized water Inorganic materials 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 210000004207 dermis Anatomy 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 229910001873 dinitrogen Inorganic materials 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 230000000688 enterotoxigenic effect Effects 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 210000001508 eye Anatomy 0.000 description 1
• 210000003746 feather Anatomy 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 239000013568 food allergen Substances 0.000 description 1
• 244000053095 fungal pathogen Species 0.000 description 1
• QPJBWNIQKHGLAU-IQZHVAEDSA-N ganglioside GM1 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 QPJBWNIQKHGLAU-IQZHVAEDSA-N 0.000 description 1
• 230000030414 genetic transfer Effects 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 235000021312 gluten Nutrition 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 150000002339 glycosphingolipids Chemical class 0.000 description 1
• 208000001786 gonorrhea Diseases 0.000 description 1
• 210000004013 groin Anatomy 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 239000000118 hair dye Substances 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 210000002837 heart atrium Anatomy 0.000 description 1
• 229940037467 helicobacter pylori Drugs 0.000 description 1
• 208000029570 hepatitis D virus infection Diseases 0.000 description 1
• 235000008216 herbs Nutrition 0.000 description 1
• 229930186900 holotoxin Natural products 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 244000052637 human pathogen Species 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 229940127121 immunoconjugate Drugs 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 230000002055 immunohistochemical effect Effects 0.000 description 1
• 230000001024 immunotherapeutic effect Effects 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 201000006747 infectious mononucleosis Diseases 0.000 description 1
• 208000000509 infertility Diseases 0.000 description 1
• 230000036512 infertility Effects 0.000 description 1
• 208000021267 infertility disease Diseases 0.000 description 1
• 239000003999 initiator Substances 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 239000011147 inorganic material Substances 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 229910052741 iridium Inorganic materials 0.000 description 1
• GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 206010023497 kuru Diseases 0.000 description 1
• 229940115932 legionella pneumophila Drugs 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000021633 leukocyte mediated immunity Effects 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 239000003589 local anesthetic agent Substances 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 150000002690 malonic acid derivatives Chemical class 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 210000004779 membrane envelope Anatomy 0.000 description 1
• WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000009740 moulding (composite fabrication) Methods 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 210000001167 myeloblast Anatomy 0.000 description 1
• 201000009240 nasopharyngitis Diseases 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 229910052759 nickel Inorganic materials 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 235000014571 nuts Nutrition 0.000 description 1
• 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 208000002042 onchocerciasis Diseases 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 239000011368 organic material Substances 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 108700025694 p53 Genes Proteins 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 229940051027 pasteurella multocida Drugs 0.000 description 1
• 235000020232 peanut Nutrition 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 239000002304 perfume Substances 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 235000020030 perry Nutrition 0.000 description 1
• 239000002831 pharmacologic agent Substances 0.000 description 1
• 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
• OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
• 239000001739 pinus spp. Substances 0.000 description 1
• 229940127126 plasminogen activator Drugs 0.000 description 1
• 231100000614 poison Toxicity 0.000 description 1
• 239000002574 poison Substances 0.000 description 1
• 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
• 229940065514 poly(lactide) Drugs 0.000 description 1
• 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
• 108010011110 polyarginine Proteins 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 108010055896 polyornithine Proteins 0.000 description 1
• 229920002714 polyornithine Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 235000008476 powdered milk Nutrition 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 108010015796 prolylisoleucine Proteins 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• 235000009736 ragweed Nutrition 0.000 description 1
• 102000016914 ras Proteins Human genes 0.000 description 1
• 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108020004418 ribosomal RNA Proteins 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 239000005060 rubber Substances 0.000 description 1
• 201000005404 rubella Diseases 0.000 description 1
• 150000003873 salicylate salts Chemical class 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 206010039447 salmonellosis Diseases 0.000 description 1
• 238000005070 sampling Methods 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 208000008864 scrapie Diseases 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 235000015170 shellfish Nutrition 0.000 description 1
• 201000005113 shigellosis Diseases 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 210000001626 skin fibroblast Anatomy 0.000 description 1
• 208000019116 sleep disease Diseases 0.000 description 1
• 229940054269 sodium pyruvate Drugs 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 229940063675 spermine Drugs 0.000 description 1
• 238000005507 spraying Methods 0.000 description 1
• 238000012289 standard assay Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 229940124530 sulfonamide Drugs 0.000 description 1
• 150000003456 sulfonamides Chemical class 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 230000001360 synchronised effect Effects 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 108010061238 threonyl-glycine Proteins 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 229940031572 toxoid vaccine Drugs 0.000 description 1
• 210000003412 trans-golgi network Anatomy 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 208000037956 transmissible mink encephalopathy Diseases 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 229950002929 trinitrophenol Drugs 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 229940036248 turpentine Drugs 0.000 description 1
• 201000008297 typhoid fever Diseases 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 238000001291 vacuum drying Methods 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• 230000017613 viral reproduction Effects 0.000 description 1
• 210000002845 virion Anatomy 0.000 description 1
• 238000003260 vortexing Methods 0.000 description 1
• 210000002268 wool Anatomy 0.000 description 1
• 229910000859 α-Fe Inorganic materials 0.000 description 1